Education
About Us
Working with TipRanks
Follow Us
VITA 34 AG (GB:0NLV)
LSE:0NLV
0NLV Stock Chart & Stats
Day’s Range― - ―
52-Week Range€4.00 - €9.80
Previous CloseN/A
Volume0.00
Average Volume (3M)247.00
Market Cap
€100.23M
Enterprise Value€85.60M
Total Cash (Recent Filing)€11.50M
Total Debt (Recent Filing)€19.67M
Price to Earnings (P/E)27.5
Beta1.00
Next Earnings
Nov 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding17,640,104
10 Day Avg. Volume50
30 Day Avg. Volume247
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.00Price Target Upside22.81% Upside
Rating ConsensusHold
Number of Analyst Covering0
0NLV FAQ
What was VITA 34 AG’s price range in the past 12 months?
VITA 34 AG lowest share price was €4.00 and its highest was €9.80 in the past 12 months.
What is VITA 34 AG’s market cap?
VITA 34 AG’s market cap is €100.23M.
When is VITA 34 AG’s upcoming earnings report date?
VITA 34 AG’s upcoming earnings report date is Nov 21, 2025 which is in 54 days.
How were VITA 34 AG’s earnings last quarter?
VITA 34 AG released its earnings results on Aug 27, 2025. The company reported €0.038 earnings per share for the quarter, beating the consensus estimate of N/A by €0.038.
Is VITA 34 AG overvalued?
According to Wall Street analysts VITA 34 AG’s price is currently Undervalued.
Does VITA 34 AG pay dividends?
VITA 34 AG does not currently pay dividends.
What is VITA 34 AG’s EPS estimate?
VITA 34 AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VITA 34 AG have?
VITA 34 AG has 17,640,104 shares outstanding.
What happened to VITA 34 AG’s price movement after its last earnings report?
VITA 34 AG reported an EPS of €0.038 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 10.853%.
Which hedge fund is a major shareholder of VITA 34 AG?
Currently, no hedge funds are holding shares in GB:0NLV
VITA 34 Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€7.00 (22.81% Upside)
€7.00 (22.81% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.55%
12-Months-Change
Fundamentals
Return on Equity
-53.67%
Trailing 12-Months
Asset Growth
-0.15%
Trailing 12-Months
Company Description
VITA 34 AG
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
Technical Analysis
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
HAEMATO AG
―
Gesundheitswelt Chiemgau AG
―
MPH Health Care AG
―